Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCG”

402 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 402 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Ended earlyNCT03719300
What this trial is testing

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Anchiano Therapeutics Israel Ltd. 32
Post-approval studies (Phase 4)UnknownNCT00242047
What this trial is testing

Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

Who this might be right for
Tuberculosis
University of Cape Town 12,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT02081326
What this trial is testing

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type OneDiabetes Mellitus, Type IAutoimmune Diabetes+1 more
Massachusetts General Hospital 150
Large-scale testing (Phase 3)Study completedNCT03947138
What this trial is testing

GC3107(BCG Vaccine) in Healthy Infants

Who this might be right for
BCG Vaccination ReactionTuberculosis
Green Cross Corporation 750
Testing effectiveness (Phase 2)UnknownNCT05564897
What this trial is testing

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Study completedNCT04884308
What this trial is testing

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

Who this might be right for
Cystic FibrosisBronchiectasis AdultNon-Tuberculous Mycobacteria
Johns Hopkins University 30
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Large-scale testing (Phase 3)Study completedNCT01316874
What this trial is testing

Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)

Who this might be right for
Carcinoma in SituBladder Cancer
Endo Pharmaceuticals 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07094711
What this trial is testing

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)

Who this might be right for
Mycobacterium Avium-intracellulare InfectionMycobacterium Infections, Nontuberculous
University of Virginia 48
Testing effectiveness (Phase 2)Looking for participantsNCT07122414
What this trial is testing

Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd 80
Testing effectiveness (Phase 2)Study completedNCT01697306
What this trial is testing

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
A.O.U. Città della Salute e della Scienza 120
Early research (Phase 1)Study completedNCT00396370
What this trial is testing

BCG Vaccination Delivered Intradermally, Orally and by Combined Routes

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 69
Large-scale testing (Phase 3)Ended earlyNCT02982395
What this trial is testing

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Who this might be right for
Non Muscle Invasive Bladder Cancer
Samyang Biopharmaceuticals Corporation 36
Large-scale testing (Phase 3)UnknownNCT03664869
What this trial is testing

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 300
Not applicableStudy completedNCT00539773
What this trial is testing

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Who this might be right for
Transitional Carcinoma of Urinary Bladder
King Faisal Specialist Hospital & Research Center 10
Not applicableStudy completedNCT02088892
What this trial is testing

A Clinical Challenge Study of BCG in Healthy Volunteers

Who this might be right for
Tuberculosis
University of Oxford 52
Testing effectiveness (Phase 2)Ended earlyNCT01118351
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Who this might be right for
Recurrent Bladder CancerTransitional Cell Carcinoma of the Bladder
Case Comprehensive Cancer Center 19
Not applicableUnknownNCT04298073
What this trial is testing

Skipping BCG for T1a Urinary Bladder Tumor.

Who this might be right for
Superficial Bladder Cancer t1a
Assiut University 43
Load More Results